source Post navigation Biomea Fusion Announces Acceptance of Three Abstracts for its Novel Menin Inhibitor Highlighting Durable Glycemic Control in Diabetes Patients at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in 2024 – Yahoo Finance A New Match for Menopausal Weight Gain: Ozempic – The New York Times
